Clovis Oncology Inc (fka CLVSQ) (CLVSQ): Clovis Oncology (NASDAQ:CLVS) upgraded t...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Friday, 09/23/2016 1:52:05 PM

Friday, September 23, 2016 1:52:05 PM

Clovis Oncology (NASDAQ:CLVS) upgraded to Outperform from Neutral by Credit Suisse.

Price target raised to $41 (7% upside) from $19.

Keep Last Read

Next 10 Prev Next

Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/18/2023 04:15:24 AM
Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/11/2023 04:09:55 PM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/11/2023 04:05:29 PM
Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/11/2023 03:43:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:37:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 09:08:05 PM

InvestorsHub NewsWire

Only $200 per official company press release!